Fresenius Medical Care AG当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗服务供应商行业排名47/78位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价28.05。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Fresenius Medical Care AG评分
相关信息
行业排名
47 / 78
全市场排名
216 / 4582
所属行业
医疗服务供应商
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
7
位分析师
持有
评级
28.046
目标均价
+22.85%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Fresenius Medical Care AG亮点
亮点风险
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
公司代码FMS
公司Fresenius Medical Care AG
CEOCordola (Craig)
网址https://www.freseniusmedicalcare.com/
常见问题
Fresenius Medical Care AG(FMS)的当前股价是多少?
Fresenius Medical Care AG(FMS)的当前股价是 23.515。
Fresenius Medical Care AG的股票代码是什么?
Fresenius Medical Care AG的股票代码是FMS。
Fresenius Medical Care AG股票的52周最高点是多少?
Fresenius Medical Care AG股票的52周最高点是30.460。
Fresenius Medical Care AG股票的52周最低点是多少?
Fresenius Medical Care AG股票的52周最低点是22.050。
Fresenius Medical Care AG的市值是多少?
Fresenius Medical Care AG的市值是6.82B。
Fresenius Medical Care AG的净利润是多少?
Fresenius Medical Care AG的净利润为581.79M。
现在Fresenius Medical Care AG(FMS)的股票是买入、持有还是卖出?
根据分析师评级,Fresenius Medical Care AG(FMS)的总体评级为持有,目标价格为28.046。
Fresenius Medical Care AG(FMS)股票的每股收益(EPS TTM)是多少
Fresenius Medical Care AG(FMS)股票的每股收益(EPS TTM)是1.359。